Associates of Cape Cod, Inc.
Associates of Cape Cod is a biotechnology firm and wholly-owned subsidiary of Seikagaku Group that develops and manufactures LAL-based bacterial endotoxin testing reagents, recombinant cascade reagents, and the Fungitell assay for invasive fungal infection screening, serving pharmaceutical, medical device, and clinical laboratory customers globally.
- Company typePrivate
- Founded1974
- HeadquartersEast Falmouth, United States
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Associates of Cape Cod, Inc. does
Associates of Cape Cod, Inc. (ACC) is a privately held biotechnology firm founded in 1974 and headquartered in East Falmouth, Massachusetts, operating as a wholly-owned subsidiary of Japan's Seikagaku Group. The company specializes in bacterial endotoxin testing (BET) and (1→3)-β-D-glucan detection, holding the distinction of being the first U.S. FDA-licensed manufacturer of Limulus Amebocyte Lysate (LAL) reagents and the developer of Fungitell, the only FDA-cleared and CE-marked rapid screening test for invasive fungal infection (IFI).
ACC's product portfolio spans LAL reagents (Pyrotell), recombinant cascade reagents (PyroSmart NextGen, launched 2021), chromogenic and turbidimetric BET methods, glucan detection products, the Fungitell and Fungitell STAT clinical assays, plus integrated hardware (Agilent BioTek Epoch 2) and software (Pyros eXpress). The underlying technology architecture combines traditional horseshoe-crab-derived LAL biochemistry with newer recombinant alternatives, validated against FDA, USP, EP, and JP pharmacopeia standards.
ACC generates revenue through four streams: (1) one-time sales of BET reagents, accessories, hardware, and software; (2) contract test services from a GMP-compliant, ISO-registered laboratory offering outsourced endotoxin testing; (3) clinical diagnostics product sales (Fungitell assays); and (4) Beacon Diagnostics Laboratory, a CLIA-certified reference lab providing (1→3)-β-D-glucan analysis services. The company serves pharmaceutical and biopharmaceutical manufacturers (primary), medical device manufacturers, and clinical/reference laboratories via direct sales and a global distributor network, with a European headquarters in Liverpool, UK supporting international expansion.
Associates of Cape Cod, Inc. firmographics
Firmographics- Name
- Associates of Cape Cod, Inc.
- Legal name
- Associates of Cape Cod, Inc.
- Website
- https://acciusa.com
- Company type
- Private
- Founded year
- 1974
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Associates of Cape Cod is a biotechnology firm and wholly-owned subsidiary of Seikagaku Group that develops and manufactures LAL-based bacterial endotoxin testing reagents, recombinant cascade reagents, and the Fungitell assay for invasive fungal infection screening, serving pharmaceutical, medical device, and clinical laboratory customers globally.
- Ownership category
- akta.pro rank
Associates of Cape Cod, Inc. industry classification
Industry- Product category
- In Vitro Diagnostics
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Medical and Diagnostic Laboratories (6215), Medical Laboratories (621511)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071), Services-Testing Laboratories (8734)
- akta.pro primary industry
- Microbiology & Sterility Assurance (Bioburden/Endotoxin/Sterility) (HLAGADAE)
- akta.pro secondary industries
- Microbiology & Infectious Disease Testing Laboratories (HLAFAMAD), Microbiology & Infectious Disease Testing (Trial Support) (HLAGAEAF)
Keywords
Where Associates of Cape Cod, Inc. is headquartered
LocationHeadquarters
- HQ city
- East Falmouth
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Associates of Cape Cod, Inc. business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- BET Products Sales: Sale of LAL reagents, recombinant cascade reagents, glucan detection products, accessories, hardware and software for bacterial endotoxin testing
- Contract Test Services: GMP-compliant and ISO-registered laboratory offering custom BET testing services including gel-clot, chromogenic, and turbidimetric methods
- Clinical Diagnostics Products: Sale of Fungitell® and Fungitell STAT® assays for invasive fungal infection screening
- Beacon Diagnostics Laboratory Services: CLIA-certified reference laboratory providing (1→3)-β-D-glucan analysis services for IFI diagnosis
Go-to-market motion1 record
Distribution channels4 records
Marketing channels6 records
Associates of Cape Cod, Inc. product offering
Product offeringCore offering
Associates of Cape Cod manufactures and sells FDA-licensed LAL reagents (gel-clot, chromogenic, turbidimetric) and the recombinant PyroSmart NextGen® cascade reagent for bacterial endotoxin testing, alongside the Fungitell® and Fungitell STAT® clinical assays for invasive fungal infection screening. The company complements its reagent portfolio with GMP-compliant contract testing services, the CLIA-certified Beacon Diagnostics reference laboratory, technical support, training programs, and supporting hardware/software (Pyros® eXpress, BioTek Epoch 2).
Product overview
Associates of Cape Cod (ACC) offers a unified portfolio centered on bacterial endotoxin testing (BET) and invasive fungal infection (IFI) diagnostics. The BET portfolio includes Pyrotell® (the first FDA-licensed LAL reagent), recombinant cascade reagents (PyroSmart NextGen®), chromogenic and turbidimetric methods, plus hardware (BioTek Epoch 2), software (Pyros® eXpress), and automation solutions. For clinical diagnostics, ACC provides the Fungitell® and Fungitell STAT® assays—the only FDA-cleared and CE-marked rapid IFI tests—supported by the Beacon Diagnostics Laboratory (CLIA-certified). Both portfolios are backed by contract testing services, technical training, and educational resources including APR Endotoxin Supplements and workshops. ACC operates as part of the Seikagaku Group, with over 50 years of industry experience.
Differentiator
Problem solved
Functional benefit
Brands
- Fungitell: FDA-cleared and CE-marked rapid screening test for invasive fungal infection (IFI) that detects (1→3)-β-D-glucan in serum.
- Fungitell STAT
- PyroSmart NextGen
- Pyrotell
- Beacon Diagnostics
Products and services
- Pyrotell® The first U.S. FDA-licensed gel-clot LAL assay for qualitative bacterial endotoxin testing; a foundational reagent in ACC's BET portfolio for pharmaceutical and medical device customers.
- LAL Reagents FDA-licensed Limulus Amebocyte Lysate reagents for bacterial endotoxin detection, available in gel-clot, chromogenic, and turbidimetric methods for pharmaceutical, biopharmaceutical, and medical device customers.
- PyroSmart NextGen® Recombinant Cascade Reagent (rCR) offering a sustainable, animal-free alternative to traditional LAL methods for bacterial endotoxin testing; officially approved for release testing by several regulatory agencies worldwide.
- Glucan Detection Products Products for detecting (1→3)-β-D-glucan contamination, complementing ACC's endotoxin testing portfolio for pharmaceutical and clinical customers.
- Fungitell® Assay The only FDA-cleared and CE-marked rapid test for invasive fungal infection (IFI) that detects (1→3)-β-D-glucan in serum, for hospital and reference laboratories screening immunocompromised patients.
- Fungitell STAT® Assay Rapid screening platform for invasive fungal infections that delivers faster results than the standard Fungitell® assay, for in-house and external clinical diagnostics labs.
- Contract Test Services (CTS) GMP-compliant and ISO-registered laboratory offering custom bacterial endotoxin testing services (gel-clot, chromogenic, turbidimetric) and glucan contamination testing to FDA, USP, EP, and/or JP standards for pharmaceutical and medical device customers needing outsourced testing.
- Inter Laboratory Performance Qualification (ILPQ) Proficiency testing service that allows laboratories to validate their performance in bacterial endotoxin testing against an external benchmark.
- Beacon Diagnostics Laboratory CLIA-certified reference laboratory specializing in (1→3)-β-D-glucan analysis services for invasive fungal infection diagnosis, providing clinical and reference laboratories with a rapid, cost-effective outsourced alternative to in-house IFI testing.
- Pyros® eXpress Software Proprietary software platform integrated with the BioTek Epoch 2 microplate spectrophotometer for data collection, analysis, and reporting of endotoxin test methods.
Companies that use Associates of Cape Cod, Inc.
Customer profileSegments3 records
Ideal customer profiles3 records
Associates of Cape Cod, Inc. technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Associates of Cape Cod, Inc. partnerships and signals
Strategic signalScale indicators2 records
Recent moves6 records
Expansion highlights5 records
Associates of Cape Cod, Inc. competitors and assessment
Company assessmentBroad incumbents
- MilliporeSigma (Merck KGaA Life Science): MilliporeSigma sells endotoxin testing reagents, kits, and reference standards as part of its broader bioprocessing and lab products portfolio, serving the same pharma/biopharma QC customers as ACC.
- bioMérieux: bioMérieux is a global leader in clinical microbiology and industrial sterility testing, with endotoxin testing reagents (ENDONEXT, ENDOLISA) and BACT/ALERT blood culture products that overlap with ACC's BET reagents and Fungitell IFI diagnostics.
- Thermo Fisher Scientific: Through its Life Sciences and Specialty Diagnostics segments, Thermo Fisher offers Pierce LAL endotoxin detection reagents and complementary microbiology/QC products, overlapping with ACC's BET reagents and clinical diagnostics portfolio.
Emerging players
- Eurofins Scientific: Eurofins provides a global contract testing network including pharmaceutical microbiology and endotoxin testing services that overlap with ACC's GMP-compliant Contract Test Services (CTS) offering.
- Sotera Health (Nelson Labs): Nelson Labs, a Sotera Health company, offers sterility and endotoxin testing services to medical device and pharmaceutical manufacturers, directly competing with ACC's CTS in outsourced BET.
Regional players
- WuXi AppTec: WuXi AppTec provides biologics testing and contract laboratory services including endotoxin and microbiology assays, comparable to ACC's CTS for global biopharma customers, with stronger Asia-Pacific presence.
Others
- Seikagaku Corporation: Seikagaku Corporation is ACC's Japanese parent company and global pharmaceutical/medical specialty player; while not a direct product competitor, it owns and strategically controls ACC and shapes its global growth direction.
Direct peers
- Charles River Laboratories: Charles River operates the Endosafe® line of LAL reagents, cartridges, and endotoxin testing services — directly competing with ACC's Pyrotell®, PyroSmart NextGen®, and CTS offerings for the same pharma/biopharma and medical-device customers.
- FUJIFILM Wako Pure Chemical Corporation: FUJIFILM Wako manufactures Limulus PS Single Test and other LAL-based endotoxin detection reagents widely used in Japanese and global pharma QC labs, competing head-to-head with ACC's Pyrotell® and recombinant reagents.
- Lonza Group: Lonza's Bioscience Solutions segment produces kinetic chromogenic LAL reagents and endotoxin testing products used by pharma manufacturers for release testing, making it a direct competitor in the bacterial endotoxin testing reagents market.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Associates of Cape Cod, Inc. social profiles
Digital presenceAssociates of Cape Cod, Inc. financial estimates
Financial estimateRevenue estimate
Valuation estimate
Associates of Cape Cod, Inc. leadership team
Management profileNumber of profiles
Profiles1 record
Associates of Cape Cod, Inc. funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Associates of Cape Cod, Inc. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Associates of Cape Cod, Inc.
What does Associates of Cape Cod, Inc. do?
Associates of Cape Cod manufactures and sells FDA-licensed LAL reagents (gel-clot, chromogenic, turbidimetric) and the recombinant PyroSmart NextGen® cascade reagent for bacterial endotoxin testing, alongside the Fungitell® and Fungitell STAT® clinical assays for invasive fungal infection screening. The company complements its reagent portfolio with GMP-compliant contract testing services, the CLIA-certified Beacon Diagnostics reference laboratory, technical support, training programs, and supporting hardware/software (Pyros® eXpress, BioTek Epoch 2).
Is Associates of Cape Cod, Inc. a public or private company?
Associates of Cape Cod, Inc. is a private company. It is classified as corporate owned and is currently operating.
When was Associates of Cape Cod, Inc. founded?
Associates of Cape Cod, Inc. was founded in 1974. It employs 101 to 250 people.
Where is Associates of Cape Cod, Inc. based?
Associates of Cape Cod, Inc. is headquartered in East Falmouth, United States, in the North America region.
How does Associates of Cape Cod, Inc. make money?
Four revenue lines are on record. BET Products Sales are the primary driver. The others are contract Test Services, clinical Diagnostics Products and beacon Diagnostics Laboratory Services.
Who are Associates of Cape Cod, Inc.'s main competitors?
Broad incumbents on record are MilliporeSigma (Merck KGaA Life Science), bioMérieux and Thermo Fisher Scientific. Emerging players are Eurofins Scientific and Sotera Health (Nelson Labs). WuXi AppTec is listed as a regional player. Seikagaku Corporation is listed as an others. Direct peers are Charles River Laboratories, FUJIFILM Wako Pure Chemical Corporation and Lonza Group.
Does Associates of Cape Cod, Inc. have an API?
No public API is recorded for Associates of Cape Cod, Inc..
What industry is Associates of Cape Cod, Inc. in?
Associates of Cape Cod, Inc.'s product category is In Vitro Diagnostics. Its primary akta.pro industry code is HLAGADAE, Microbiology & Sterility Assurance (Bioburden/Endotoxin/Sterility), with a secondary code of HLAFAMAD, Microbiology & Infectious Disease Testing Laboratories. Its NAICS code is 325413 and its SIC code is 2835.